Quest Diagnostics (DGX) Tops Q3 EPS by 4c; raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $254.93 +3.19%
Financial Fact:
Other (expense) income, net: 4M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Other (expense) income, net: 4M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $2.30, $0.04 better than the analyst estimate of $2.26. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.43 billion.
GUIDANCE:
Quest Diagnostics sees FY2024 EPS of $8.85-$8.95, versus the consensus of $8.89. Quest Diagnostics sees FY2024 revenue of $9.8-9.85 billion, versus the consensus of $9.657 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Twilio (TWLO) PT Raised to $320 at Tigress Financial Partners
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
